UpdatED: The emergency medicine pharmacotherapy literature of 2022
P Sarangarm, DE Zimmerman, B Faine… - The American journal of …, 2023 - Elsevier
The purpose of this article is to summarize pharmacotherapy related emergency medicine
(EM) literature indexed in 2022. Articles were selected utilizing a modified Delphi approach …
(EM) literature indexed in 2022. Articles were selected utilizing a modified Delphi approach …
[HTML][HTML] Formulation, characterization, and optimization of a topical gel containing tranexamic acid to prevent superficial bleeding: In vivo and in vitro evaluations
F Shiehzadeh, D Mohebi, O Chavoshian… - Turkish Journal of …, 2023 - ncbi.nlm.nih.gov
Objectives: Tranexamic acid (TXA) is used systemically to stop bleeding, but it can lead to
thromboembolism. Trials have revealed the efficacy of topical TXA on local hemorrhages …
thromboembolism. Trials have revealed the efficacy of topical TXA on local hemorrhages …
Comparative effectiveness of various noninvasive local treatments in patients with epistaxis: A systematic review and network meta‐analysis
Background The best initial strategy for managing epistaxis is unclear. We performed a
systematic review and network meta‐analysis (NMA) to compare the effectiveness of various …
systematic review and network meta‐analysis (NMA) to compare the effectiveness of various …
Managing epistaxis
M Gottlieb, B Long - Annals of Emergency Medicine, 2023 - annemergmed.com
[Ann Emerg Med. 2023; 81: 234-240.] Epistaxis is a common emergency department (ED)
presentation, accounting for approximately 1-in-200 visits in the United States. 1 It has a …
presentation, accounting for approximately 1-in-200 visits in the United States. 1 It has a …
Efficacy of tranexamic acid in nasopharyngeal hemorrhage; single center prospective study and literature review
S Haldun, AI Suceveanu, M Lupascu… - Journal of Mind and …, 2024 - scholar.valpo.edu
Nasopharyngeal hemorrhage is one of the most common ear, nose, and throat (ENT)
emergencies that present in a hospital or primary care clinic. While many cases of …
emergencies that present in a hospital or primary care clinic. While many cases of …
Can't Stop, won't stop: the return of tranexamic acid for epistaxis
MA Rech, M Gottlieb - Annals of Emergency Medicine, 2022 - annemergmed.com
Epistaxis is a common condition, affecting up to 60% of the population and accounting for 1
in 200 emergency department (ED) visits. 1, 2 It is mostly self-limiting, but up to 6% of …
in 200 emergency department (ED) visits. 1, 2 It is mostly self-limiting, but up to 6% of …
Journal update monthly top five
G Prager, G Oliver, AJN Jafar, D Darbyshire… - Emergency Medicine …, 2022 - emj.bmj.com
This month's update has been prepared by the Emergency Medicine & Intensive Care
Research Group (EMERGING) from Manchester. We used a multimodal search strategy …
Research Group (EMERGING) from Manchester. We used a multimodal search strategy …
and Management in Patients Taking Antiplatelet Drugs
S Winograd - platelets - search.ebscohost.com
This text provides information on the common condition of nosebleeds, or epistaxis, which
affects a significant portion of the population. It discusses the causes of nosebleeds …
affects a significant portion of the population. It discusses the causes of nosebleeds …
Uso del ácido tranexámico en el sangrado nasal no controlado: revisión sistemática
M Álvarez Vizcaya - 2023 - titula.universidadeuropea.com
Introducción: La epistaxis es la hemorragia nasal resultado de una interacción de factores
que dañan el revestimiento del epitelio y las paredes de los vasos. Suele ser leve y …
que dañan el revestimiento del epitelio y las paredes de los vasos. Suele ser leve y …
Effectiveness of tranexamic acid for acute traumatic hemorrhage and epistaxis in settings without immediate surgical support: a literature review
C Rots - 2024 - mspace.lib.umanitoba.ca
Background: Tranexamic acid has been widely used for the management of acute
hemorrhage. Although results remain conflicting on its benefits, several more studies have …
hemorrhage. Although results remain conflicting on its benefits, several more studies have …